Johnson & Johnson sales for the fourth quarter of 2014 were almost flat at 0.6% down to $18.3 billion. Worldwide sales for the full-year rose 4.2% to $74.3 billion. “2014 was a strong year for Johnson & Johnson, as we delivered solid financial results while continuing to make investments to accelerate growth for the long term. We have built significant momentum in our pharmaceutical business, are realizing the benefits of innovation, scale and breadth in our medical devices business...